Skip to main content
Claresa Levetan, MD, Endocrinology, Lansdale, PA, Thomas Jefferson University Hospitals

ClaresaSharonLevetanMD

Endocrinology Lansdale, PA

Diabetes, Lipid Metabolism

Physician

Dr. Levetan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Levetan's full profile

Already have an account?

Summary

  • I am an endocrinologist with special interest in type 1 diabetes and also disease.

Education & Training

  • Icahn School of Medicine at Mount Sinai (Beth Israel)
    Icahn School of Medicine at Mount Sinai (Beth Israel)Fellowship, Endocrinology, Diabetes, and Metabolism, 1988 - 1990
  • Icahn School of Medicine at Mount Sinai (Beth Israel)
    Icahn School of Medicine at Mount Sinai (Beth Israel)Residency, Internal Medicine, 1986 - 1988
  • Emory University School of Medicine
    Emory University School of MedicineResidency, Psychiatry, 1983 - 1984
  • Emory University School of Medicine
    Emory University School of MedicineClass of 1983
  • University of Georgia
    University of GeorgiaBS, Microbiology, 1977 - 1979

Certifications & Licensure

  • PA State Medical License
    PA State Medical License 2002 - 2022
  • PA State Medical License
    PA State Medical License 2002 - 2022
  • GA State Medical License
    GA State Medical License 1984 - 1989
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

  • Fellow (FACE) American Association of Clinical Endocrinology
  • Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
  • Distinction in the Art and Science of Endocrinology American College of Endocrinology, 2007
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • Islet Neogenesis Therapy from Endogenous Pancreatic Stem Cells without Transplantation: Will Type 1 and Type 2 Diabetes Soon be Diseases of the Past?  
    Levetan C, J Diabetes Treat, 1/1/2017
  • Proposal for generating new beta cells in a muted immune environment for type 1 diabetes  
    Levetan C, Pozzilli P, Jovanovic L, Schatz D, Diabetes Metab Res Rev, 1/12/2013
  • Distinctions between islet neogenesis and Beta-cell replication: Implications for reversal of Type 1 and 2 diabetes  
    Levetan C, Journal of Diabetes, 1/1/2010
  • Join now to see all

Abstracts/Posters

  • Impact of pramlintide on glucose among intensively treated type 1 diabetes patients using insulin pumps.
    Levetan CS, Want L, Mudaliar S, Henry RR, Maggs DG, Weyer C, Kolterman OG, Diabetes, 1/1/2002
  • Improved postprandial of pramlintide on insulin requirements and postprandial glucose and triglyceride concentrations among well-controlled patients with type 1 diabet...
    Levetan CS, Want L, Mudaliar S, Henry RR, Maggs DG, Weyer C, Kolterman OG, Diabetes, 1/1/2002
  • Impact of Pramlintide on the Amplitude of Glycemic Excursions.
    Levetan CS, Want LL, Diabetes, 1/1/2001
  • Join now to see all

Hospital Affiliations